JLGH Spring 2024 Recap
Q&A for Extended Learning
Q: What is clinical inertia? How can the medical community reduce its risk in patient care?
A: Clinical inertia is the failure to accelerate or change therapy to meet the standard of care. Solutions can include targeted guidance, ongoing peer review, and studies focused on how to better serve patients.
Read the article.
Q: American Diabetes Association (ADA) guidelines suggest a patient-centered, collaborative, multidisciplinary care team of pharmacists, nurses, or dieticians, among other health care professionals, that prioritizes timely follow-up and medication adjustments in patients with type 2 diabetes mellitus and an A1C not at goal. How soon do the ADA guidelines recommend treatment initiation or intensification?
A: The guidelines recommend treatment initiation or intensification within three months of findings.
Q: Although the side effect profile and other potential adverse effects of duloxetine warrant consideration, this drug remains effective for what clinical syndromes?
A: Duloxetine is approved for the treatment of mental health disorders such as major depression and generalized anxiety disorder, as well as pain syndromes such as fibromyalgia, chronic musculoskeletal pain, and diabetic neuropathy.
Q: List some practical applications of text message reminders in outpatient practices.
A: Text message medical reminders (TMMRs) can help improve compliance with preventive screenings, wellness checks for pediatric patients, and annual physicals for adults. TMMRs might also help increase vaccination rates for yearly inoculations, such as the flu vaccine.
Q: In patients with repetitive monomorphic ventricular tachycardia who have symptoms of palpitations but are not ready for ablation, what medical treatment can be offered?
A: Although radiofrequency ablation may resolve the symptoms, patients may be treated with beta-blockers, calcium channel blockers, or antiarrhythmic medications.
Q: Why might we consider continuing the outpatient dose of buprenorphine in a patient being admitted to an inpatient service?
A: Patients who continue their outpatient dose of buprenorphine in the inpatient setting have overall lower morphine milligram equivalents (MME) needs while inpatients. They also require significantly fewer MME to achieve similar pain scores, have reduced opioid prescription rates at discharge, and may avoid problems associated with buprenorphine reinitiation.
|